BioCentury | May 26, 2008
Company News

Alexza management update

...as president of Alexza’s Alexza Singapore Pte. Ltd. subsidiary, formerly VP of corporate development at Scion Pharmaceuticals Inc. WIR...
BioCentury | Dec 11, 2006
Company News

Scion, Xention, Bristol-Myers deal

...Xention received rights from Scion to undisclosed ion channel modulators that Scion originally licensed from BMY...
...ED). The most advanced compound has completed Phase I testing. Financial terms were not disclosed. Scion Pharmaceuticals Inc....
BioCentury | Jan 9, 2006
Company News

Cetek management update

...High throughput screening Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc....
BioCentury | Jan 17, 2005
Company News

Scion board of directors update

Scion Pharmaceuticals Inc. , Medford, Mass. Business: Neurology, Cardiovascular Hired: Barry Berkowitz as president and CEO, formerly a corporate VP at Albany Molecular Research Inc.; he replaces Pravin Chaturvedi, who departed WIR Staff Cardiovascular Neurology...
BioCentury | Jan 14, 2005
Company News

Scion names Berkowitz CEO

...a consultant to the company. Previously, Berkowitz was corporate VP at Albany Molecular Research (AMRI). Scion...
...develop small molecules for neurological and cardiovascular indications ( see BioCentury, Jan. 26, 2004 ). Scion's...
BioCentury | Apr 5, 2004
Company News

Alexza Molecular Delivery Corp. management update

...Jeffrey Williams as SVP of corporate and business development, formerly VP of corporate development at Scion Pharmaceuticals Inc. WIR...
BioCentury | Mar 15, 2004
Company News

Scion management update

Scion Pharmaceuticals Inc. , Medford, Mass. Business: Cardiovascular, Neurology Hired: Valentin Gribkoff as VP of biology, formerly senior principal scientist at the Neuroscience Drug Discovery Department of Bristol-Myers Squibb Co. 's Pharmaceutical Research Institute WIR Staff...
BioCentury | Jan 26, 2004
Emerging Company Profile

Scion: Discovery by electrophysiology

...identification. The technique has been most often reserved for more focused lead optimization work. However, Scion Pharmaceuticals Inc....
...But binding assays don't give any information about the cellular response - electrophysiology does. For Scion...
...functional information. They just tell you whether or not you are binding the receptor." Thus, Scion...
BioCentury | Jan 26, 2004
Emerging Company Profile

Corporate Profile

Scion Pharmaceuticals Inc. Medford, Mass. Technology: Ion channel-based drug discovery Disease focus: Pain and atrial fibrillation Clinical status: Preclinical Founded: 2001 by Pravin Chaturvedi, David Farb and Mark Carthy Corporate partners: None University collaborators: Boston...
BioCentury | Sep 22, 2003
Product Development

Painfully slow

...U.S. revenues for anti-epileptic and pain indications, according to Chaturvedi Pravin, president and CEO of Scion Pharmaceuticals Inc....
...NO-steroids and an NO-donating version of gabapentin to treat neuropathic pain, according to Garufi. Meanwhile, Scion...
Items per page:
1 - 10 of 22
BioCentury | May 26, 2008
Company News

Alexza management update

...as president of Alexza’s Alexza Singapore Pte. Ltd. subsidiary, formerly VP of corporate development at Scion Pharmaceuticals Inc. WIR...
BioCentury | Dec 11, 2006
Company News

Scion, Xention, Bristol-Myers deal

...Xention received rights from Scion to undisclosed ion channel modulators that Scion originally licensed from BMY...
...ED). The most advanced compound has completed Phase I testing. Financial terms were not disclosed. Scion Pharmaceuticals Inc....
BioCentury | Jan 9, 2006
Company News

Cetek management update

...High throughput screening Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc....
BioCentury | Jan 17, 2005
Company News

Scion board of directors update

Scion Pharmaceuticals Inc. , Medford, Mass. Business: Neurology, Cardiovascular Hired: Barry Berkowitz as president and CEO, formerly a corporate VP at Albany Molecular Research Inc.; he replaces Pravin Chaturvedi, who departed WIR Staff Cardiovascular Neurology...
BioCentury | Jan 14, 2005
Company News

Scion names Berkowitz CEO

...a consultant to the company. Previously, Berkowitz was corporate VP at Albany Molecular Research (AMRI). Scion...
...develop small molecules for neurological and cardiovascular indications ( see BioCentury, Jan. 26, 2004 ). Scion's...
BioCentury | Apr 5, 2004
Company News

Alexza Molecular Delivery Corp. management update

...Jeffrey Williams as SVP of corporate and business development, formerly VP of corporate development at Scion Pharmaceuticals Inc. WIR...
BioCentury | Mar 15, 2004
Company News

Scion management update

Scion Pharmaceuticals Inc. , Medford, Mass. Business: Cardiovascular, Neurology Hired: Valentin Gribkoff as VP of biology, formerly senior principal scientist at the Neuroscience Drug Discovery Department of Bristol-Myers Squibb Co. 's Pharmaceutical Research Institute WIR Staff...
BioCentury | Jan 26, 2004
Emerging Company Profile

Scion: Discovery by electrophysiology

...identification. The technique has been most often reserved for more focused lead optimization work. However, Scion Pharmaceuticals Inc....
...But binding assays don't give any information about the cellular response - electrophysiology does. For Scion...
...functional information. They just tell you whether or not you are binding the receptor." Thus, Scion...
BioCentury | Jan 26, 2004
Emerging Company Profile

Corporate Profile

Scion Pharmaceuticals Inc. Medford, Mass. Technology: Ion channel-based drug discovery Disease focus: Pain and atrial fibrillation Clinical status: Preclinical Founded: 2001 by Pravin Chaturvedi, David Farb and Mark Carthy Corporate partners: None University collaborators: Boston...
BioCentury | Sep 22, 2003
Product Development

Painfully slow

...U.S. revenues for anti-epileptic and pain indications, according to Chaturvedi Pravin, president and CEO of Scion Pharmaceuticals Inc....
...NO-steroids and an NO-donating version of gabapentin to treat neuropathic pain, according to Garufi. Meanwhile, Scion...
Items per page:
1 - 10 of 22